- Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor. Hofmann, W.K., Ganser, A., Seipelt, G., Ottmann, O.G., Zander, C., Geissler, G., Hoffmann, K., Höffken, K., Fischer, J.T., Isele, G., Hoelzer, D. Ann. Hematol. (1999)